Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O2EB
|
||||
| Former ID |
DIB004660
|
||||
| Drug Name |
F-11105
|
||||
| Indication | Asthma [ICD10:J45] | Discontinued in Phase 1 | [1] | ||
| Company |
Pierre Fabre SA
|
||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010557) | ||||
| REF 2 | US patent application no. 6,673,908, Tumor necrosis factor receptor 2. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.